These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 21033407
1. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Wasilewska A, Taranta-Janusz K, Zoch-Zwierz W, Rybi-Szumińska A, Kołodziejczyk Z. Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407 [Abstract] [Full Text] [Related]
2. Matrix metalloproteinases and their inhibitors. Kugler A. Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151 [Abstract] [Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
4. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts. Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS. Cardiology; 2009 Oct; 113(3):161-8. PubMed ID: 19129699 [Abstract] [Full Text] [Related]
5. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Baker EA, Bergin FG, Leaper DJ. Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431 [Abstract] [Full Text] [Related]
9. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX. Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283 [Abstract] [Full Text] [Related]
15. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Haeusler G, Walter I, Helmreich M, Egerbacher M. Calcif Tissue Int; 2005 May 02; 76(5):326-35. PubMed ID: 15868281 [Abstract] [Full Text] [Related]
16. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP. Am J Hypertens; 2004 Sep 02; 17(9):775-82. PubMed ID: 15363819 [Abstract] [Full Text] [Related]
18. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. He S, Prasanna G, Yorio T. Invest Ophthalmol Vis Sci; 2007 Aug 02; 48(8):3737-45. PubMed ID: 17652746 [Abstract] [Full Text] [Related]
20. [Extracellular matrix metalloproteinases--perspectives of their use in medicine]. Kotulska-Wolwender K, Larysz-Brysz M, Fus Z, Korczyńska I, Górka D, Lewin-Kowalik J. Wiad Lek; 2002 Aug 02; 55(7-8):463-71. PubMed ID: 12428575 [Abstract] [Full Text] [Related] Page: [Next] [New Search]